InMode Ltd. (INMD)
USD 16.3
(-9.34%)
USD 16.3
(-9.34%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 195.66 Million USD | -1.11% |
| 2022 | 197.85 Million USD | 18.14% |
| 2021 | 167.47 Million USD | 129.92% |
| 2020 | 72.84 Million USD | 22.18% |
| 2019 | 59.61 Million USD | 153.81% |
| 2018 | 23.48 Million USD | 162.45% |
| 2017 | 8.95 Million USD | 1237.82% |
| 2016 | 669 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 48.26 Million USD | 163.52% |
| 2024 Q2 | 18.31 Million USD | 1.23% |
| 2024 Q1 | 18.09 Million USD | -64.69% |
| 2023 Q3 | 46.41 Million USD | -18.59% |
| 2023 Q4 | 51.24 Million USD | 10.42% |
| 2023 FY | 195.66 Million USD | -1.11% |
| 2023 Q1 | 40.99 Million USD | -31.56% |
| 2023 Q2 | 57 Million USD | 39.06% |
| 2022 Q3 | 53.74 Million USD | 9.23% |
| 2022 Q4 | 59.89 Million USD | 11.45% |
| 2022 Q2 | 49.2 Million USD | 40.55% |
| 2022 Q1 | 35 Million USD | -35.35% |
| 2022 FY | 197.85 Million USD | 18.14% |
| 2021 Q1 | 26.77 Million USD | -24.46% |
| 2021 FY | 167.47 Million USD | 129.92% |
| 2021 Q3 | 45.01 Million USD | 8.38% |
| 2021 Q2 | 41.53 Million USD | 55.15% |
| 2021 Q4 | 54.15 Million USD | 20.29% |
| 2020 Q3 | 23.29 Million USD | 187.39% |
| 2020 Q1 | 6 Million USD | -66.61% |
| 2020 FY | 72.84 Million USD | 22.18% |
| 2020 Q4 | 35.44 Million USD | 52.15% |
| 2020 Q2 | 8.1 Million USD | 35.02% |
| 2019 Q1 | 9.93 Million USD | 656.44% |
| 2019 Q2 | 15.72 Million USD | 58.35% |
| 2019 FY | 59.61 Million USD | 153.81% |
| 2019 Q4 | 17.97 Million USD | 12.5% |
| 2019 Q3 | 15.98 Million USD | 1.62% |
| 2018 Q2 | 7.84 Million USD | 32.06% |
| 2018 Q4 | 1.31 Million USD | -84.36% |
| 2018 FY | 23.48 Million USD | 162.45% |
| 2018 Q3 | 8.39 Million USD | 7.03% |
| 2018 Q1 | 5.93 Million USD | 59.61% |
| 2017 Q1 | 1.19 Million USD | 0.0% |
| 2017 FY | 8.95 Million USD | 1237.82% |
| 2017 Q4 | 3.72 Million USD | 31.48% |
| 2017 Q3 | 2.83 Million USD | -11.23% |
| 2017 Q2 | 3.18 Million USD | 165.78% |
| 2016 FY | 669 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -14.36 Million USD | 1462.44% |
| Cerus Corporation | -30.05 Million USD | 751.05% |
| OrthoPediatrics Corp. | -25.76 Million USD | 859.373% |
| PetVivo Holdings, Inc. | -10.62 Million USD | 1942.14% |
| Talis Biomedical Corporation | -66.81 Million USD | 392.838% |
| Vivos Therapeutics, Inc. | -17.29 Million USD | 1231.244% |
| Inogen, Inc. | -109.38 Million USD | 278.871% |
| Spectral AI, Inc. | -12.98 Million USD | 1606.932% |
| Nano-X Imaging Ltd. | -62.58 Million USD | 412.611% |
| CVRx, Inc. | -43.1 Million USD | 553.936% |
| DIH Holding US, Inc. Warrants | -3.52 Million USD | 5645.918% |
| Helius Medical Technologies, Inc. | -12.42 Million USD | 1674.348% |
| Orthofix Medical Inc. | -139.11 Million USD | 240.651% |
| Venus Concept Inc. | -28.3 Million USD | 791.158% |
| Accelerate Diagnostics, Inc. | -54.02 Million USD | 462.146% |
| Bioventus Inc. | -81.72 Million USD | 339.413% |
| BrainsWay Ltd. | -4.92 Million USD | 4071.179% |
| Envoy Medical, Inc. | -18.37 Million USD | 1165.048% |
| electroCore, Inc. | -18.8 Million USD | 1140.468% |
| IceCure Medical Ltd | -15.57 Million USD | 1356.163% |
| Lucid Diagnostics Inc. | -48.48 Million USD | 503.572% |
| Monogram Orthopaedics, Inc. | -17.26 Million USD | 1233.077% |
| MaxCyte, Inc. | -48.29 Million USD | 505.102% |
| NeuroOne Medical Technologies Corporation | -11.95 Million USD | 1736.603% |
| Nexalin Technology, Inc. | -5.69 Million USD | 3534.864% |
| PAVmed Inc | -68.79 Million USD | 384.41% |
| Rapid Micro Biosystems, Inc. | -56.56 Million USD | 445.915% |
| RxSight, Inc. | -50.08 Million USD | 490.656% |
| Sight Sciences, Inc. | -57.27 Million USD | 441.621% |
| SI-BONE, Inc. | -46.93 Million USD | 516.91% |
| TELA Bio, Inc. | -44.07 Million USD | 543.925% |
| TriSalus Life Sciences, Inc. | -54.15 Million USD | 461.33% |
| Treace Medical Concepts, Inc. | -51.42 Million USD | 480.454% |
| LivaNova PLC | -68.49 Million USD | 385.643% |
| 908 Devices Inc. | -42.75 Million USD | 557.599% |
| Alphatec Holdings, Inc. | -173.39 Million USD | 212.841% |
| Nemaura Medical Inc. | -9.59 Million USD | 2139.137% |
| NeuroPace, Inc. | -27.17 Million USD | 820.026% |
| LENSAR, Inc. | -12.22 Million USD | 1699.967% |
| Apyx Medical Corporation | -17.25 Million USD | 1233.669% |
| Cutera, Inc. | -156.23 Million USD | 225.238% |
| STRATA Skin Sciences, Inc. | -8.6 Million USD | 2374.059% |
| BioSig Technologies, Inc. | -28.51 Million USD | 786.237% |
| Anika Therapeutics, Inc. | -87.63 Million USD | 323.257% |
| ClearPoint Neuro, Inc. | -22.44 Million USD | 971.692% |
| Integra LifeSciences Holdings Corporation | 111.52 Million USD | -75.439% |
| Axonics, Inc. | -26.05 Million USD | 850.892% |
| Outset Medical, Inc. | -169.77 Million USD | 215.25% |
| IRIDEX Corporation | -10 Million USD | 2055.231% |
| PROCEPT BioRobotics Corporation | -109.17 Million USD | 279.225% |
| IRadimed Corporation | 20.03 Million USD | -876.569% |
| Tivic Health Systems, Inc. | -8.24 Million USD | 2473.075% |
| INVO Bioscience, Inc. | -6.76 Million USD | 2991.318% |
| Telesis Bio, Inc. | -35.15 Million USD | 656.643% |
| Viemed Healthcare, Inc. | 14.33 Million USD | -1265.387% |
| Varex Imaging Corporation | 32.1 Million USD | -509.533% |
| Quipt Home Medical Corp. | 3.91 Million USD | -4892.6% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1712.627% |
| Pulmonx Corporation | -61.93 Million USD | 415.912% |
| Dynatronics Corporation | -2.27 Million USD | 8707.825% |
| Modular Medical, Inc. | -17.52 Million USD | 1216.207% |
| ReShape Lifesciences Inc. | -14.63 Million USD | 1436.567% |
| Semler Scientific, Inc. | 22.25 Million USD | -779.134% |
| Bruker Corporation | 436.9 Million USD | 55.216% |
| Cytosorbents Corporation | -31.2 Million USD | 726.929% |
| DexCom, Inc. | 597.7 Million USD | 67.265% |
| Align Technology, Inc. | 643.33 Million USD | 69.587% |
| Viveve Medical, Inc. | -21.55 Million USD | 1007.809% |
| ZimVie Inc. | -30.93 Million USD | 732.406% |
| Movano Inc. | -29.69 Million USD | 759.01% |
| Cytek Biosciences, Inc. | -27.84 Million USD | 802.676% |
| Nexalin Technology, Inc. | -5.69 Million USD | 3534.864% |
| DIH Holdings US, Inc. Class A Common Stock | -3.52 Million USD | 5645.918% |
| Tandem Diabetes Care, Inc. | -233.23 Million USD | 183.891% |
| Profound Medical Corp. | -28.61 Million USD | 783.743% |
| Insulet Corporation | 220 Million USD | 11.064% |
| enVVeno Medical Corporation | -25.23 Million USD | 875.26% |
| Surmodics, Inc. | -5.64 Million USD | 3566.076% |
| iCAD, Inc. | -7.68 Million USD | 2644.674% |
| Nuwellis, Inc. | -17.63 Million USD | 1209.813% |
| Biotricity, Inc. | -8.82 Million USD | 2316.29% |
| iRhythm Technologies, Inc. | -125.16 Million USD | 256.327% |
| Aethlon Medical, Inc. | -12.63 Million USD | 1648.363% |
| InspireMD, Inc. | -21.14 Million USD | 1025.413% |
| PAVmed Inc. | -68.79 Million USD | 384.41% |
| BIOLASE, Inc. | -17.93 Million USD | 1190.818% |
| Beyond Air, Inc. | -63 Million USD | 410.542% |
| FONAR Corporation | 16.53 Million USD | -1083.282% |
| AxoGen, Inc. | -21.46 Million USD | 1011.658% |
| Vivani Medical, Inc. | -26.96 Million USD | 825.607% |
| Tactile Systems Technology, Inc. | 18.04 Million USD | -984.53% |
| Inari Medical, Inc. | -14.03 Million USD | 1494.384% |
| UFP Technologies, Inc. | 57.66 Million USD | -239.31% |
| QT Imaging Holdings, Inc. | -4.92 Million USD | 4070.696% |
| Heart Test Laboratories, Inc. | -6.3 Million USD | 3202.872% |
| Tenon Medical, Inc. | -15.72 Million USD | 1344.102% |
| Autonomix Medical, Inc. Common Stock | -7.47 Million USD | 2717.875% |
| Co-Diagnostics, Inc. | -42.7 Million USD | 558.153% |
| AdaptHealth Corp. | -598.4 Million USD | 132.697% |
| Sintx Technologies, Inc. | -13.35 Million USD | 1564.74% |
| NanoVibronix, Inc. | -3.43 Million USD | 5794.412% |
| Quanterix Corporation | -49.7 Million USD | 493.674% |
| Inspira Technologies Oxy B.H.N. Ltd. | -12.13 Million USD | 1712.627% |
| Sensus Healthcare, Inc. | -382 Thousand USD | 51319.895% |
| Pacific Biosciences of California, Inc. | -334.46 Million USD | 158.499% |
| TransMedics Group, Inc. | -28.72 Million USD | 781.101% |
| ReWalk Robotics Ltd. | -23.61 Million USD | 928.646% |
| NeuroMetrix, Inc. | -7.15 Million USD | 2835.921% |
| Hyperfine, Inc. | -48.11 Million USD | 506.651% |
| Establishment Labs Holdings Inc. | -65.02 Million USD | 400.895% |
| Biomerica, Inc. | -6.36 Million USD | 3173.033% |
| Bone Biologics Corporation | -9.42 Million USD | 2175.241% |
| AVITA Medical, Inc. | -40.4 Million USD | 584.282% |
| Bluejay Diagnostics, Inc. | -10.31 Million USD | 1997.545% |
| Silk Road Medical, Inc | -59.27 Million USD | 430.111% |